Enveric Biosciences, Inc. (ENVB)Healthcare | Biotechnology | Cambridge, United States | NasdaqCM
1.82 USD
-0.53
(-22.553%) ⇩
(April 17, 2026, 4 p.m.
EDT)
After hours: 1.88 +0.06 (3.297%) ⇧ (April 17, 2026, 7:57 p.m. EDT) Short-term: ☆☆☆☆☆ | Long-term: ☆☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 18, 2026, 10:21 p.m. EDT
Enveric Biosciences presents a high-risk, speculative opportunity with strong catalyst-driven momentum for short-term trades following recent patent and data developments, but it carries a severe long-term structural warning due to significant cash burn (operating cash flow of -$8.1M), no dividends, negative forward earnings, and a -23.7% forecasted price decline from a quantitative model, reflecting deep uncertainty and balance sheet pressure despite the recent price stability. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.354040 |
| MSTL | 0.549136 |
| AutoARIMA | 0.571623 |
| AutoETS | 0.573048 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 52% |
| H-stat | 1.12 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.000 |
| Excess Kurtosis | 1.70 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Ex Dividend Date | 2008-04-22 |
| Market Cap | 3,435,315 |
| Forward P/E | -1.29 |
| Beta | 0.33 |
| Website | https://www.enveric.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.872549 |
| Address1 | 245 First Street |
| Address2 | Riverview II 18 th Floor |
| All Time High | 182,250,000.0 |
| All Time Low | 1.71 |
| Ask | 2.2 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 1,264,960 |
| Average Daily Volume3 Month | 561,872 |
| Average Volume | 561,872 |
| Average Volume10Days | 1,264,960 |
| Beta | 0.326 |
| Bid | 1.38 |
| Bid Size | 2 |
| Book Value | 3.935 |
| City | Cambridge |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 1.82 |
| Current Ratio | 5.375 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 1.9399 |
| Day Low | 1.71 |
| Display Name | Enveric Biosciences |
| Dividend Date | 1,574,640,000 |
| Earnings Timestamp End | 1,755,288,000 |
| Earnings Timestamp Start | 1,754,942,400 |
| Ebitda | -8,573,590 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | 0.145 |
| Enterprise Value | -1,242,177 |
| Eps Forward | -1.41 |
| Eps Trailing Twelve Months | -36.24 |
| Esg Populated | 0 |
| Ex Dividend Date | 1,208,908,800 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 2.06976 |
| Fifty Day Average Change | -0.24976003 |
| Fifty Day Average Change Percent | -0.120671004 |
| Fifty Two Week Change Percent | -87.2549 |
| Fifty Two Week High | 17.844 |
| Fifty Two Week High Change | -16.024 |
| Fifty Two Week High Change Percent | -0.89800495 |
| Fifty Two Week Low | 1.71 |
| Fifty Two Week Low Change | 0.110000014 |
| Fifty Two Week Low Change Percent | 0.06432749 |
| Fifty Two Week Range | 1.71 - 17.844 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,430,746,200,000 |
| Float Shares | 1,847,878 |
| Forward Eps | -1.41 |
| Forward P E | -1.2907802 |
| Free Cashflow | -4,792,909 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 5 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.03915 |
| Held Percent Institutions | 0.06278 |
| Implied Shares Outstanding | 1,887,536 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,761,609,600 |
| Last Split Factor | 1:12 |
| Long Business Summary | Enveric Biosciences, Inc., a biotechnology company, engages in the development of small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders. The company offers product candidates are EB-002, an active metabolite of psilocybin, which is in preclinical development stage for the treatment of anxiety disorders; and EB-003 that is in preclinical development stage for the treatment mental health. It also focuses on the development of cannabinoid conjugate molecules for the treatment of pain and cancer. The company was founded in 2020 and is headquartered in Cambridge, Massachusetts. |
| Long Name | Enveric Biosciences, Inc. |
| Market | us_market |
| Market Cap | 3,435,315 |
| Market State | PREPRE |
| Max Age | 86,400 |
| Message Board Id | finmb_650902272 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -12,131,472 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 3,425,876 |
| Open | 1.93 |
| Operating Cashflow | -8,141,543 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Post Market Change | 0.059999943 |
| Post Market Change Percent | 3.2967 |
| Post Market Price | 1.88 |
| Post Market Time | 1,776,470,270 |
| Previous Close | 2.35 |
| Price Hint | 4 |
| Price To Book | 0.4625159 |
| Profit Margins | 0.0 |
| Quick Ratio | 5.093 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.53 |
| Regular Market Change Percent | -22.5532 |
| Regular Market Day High | 1.9399 |
| Regular Market Day Low | 1.71 |
| Regular Market Day Range | 1.71 - 1.9399 |
| Regular Market Open | 1.93 |
| Regular Market Previous Close | 2.35 |
| Regular Market Price | 1.82 |
| Regular Market Time | 1,776,456,001 |
| Regular Market Volume | 1,135,430 |
| Return On Assets | -1.34109 |
| Return On Equity | -3.04037 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 1,887,535 |
| Shares Percent Shares Out | 0.0375 |
| Shares Short | 70,703 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 118,369 |
| Short Name | Enveric Biosciences, Inc. |
| Short Percent Of Float | 0.0375 |
| Short Ratio | 1.79 |
| Source Interval | 15 |
| State | MA |
| Symbol | ENVB |
| Total Cash | 4,677,491 |
| Total Cash Per Share | 2.478 |
| Total Debt | 0 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -36.24 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 7.15712 |
| Two Hundred Day Average Change | -5.33712 |
| Two Hundred Day Average Change Percent | -0.74570775 |
| Type Disp | Equity |
| Volume | 1,135,430 |
| Website | https://www.enveric.com |
| Zip | 2,142 |